I was reading an article about some of the questioning in the 5th circuit appellate court on the Mifepristone case, and they were basically questioning the validity of telemedice.
These folks are on a warpath, and have a “by any means” approach that will lay waste to a wide swath. The threshold for the “danger” presented by Mifepristone is so low you could sue to block (nation wide) almost any product. Delving into all past decisions by regulatory bodies could uproot the entire regulatory structure.
And their attitude is “don’t worry, we’re only doing it in this case.” Weak, authoritarian, capricious, anti-democratic crap.
I was reading an article about some of the questioning in the 5th circuit appellate court on the Mifepristone case, and they were basically questioning the validity of telemedice.
These folks are on a warpath, and have a “by any means” approach that will lay waste to a wide swath. The threshold for the “danger” presented by Mifepristone is so low you could sue to block (nation wide) almost any product. Delving into all past decisions by regulatory bodies could uproot the entire regulatory structure.
And their attitude is “don’t worry, we’re only doing it in this case.” Weak, authoritarian, capricious, anti-democratic crap.